These immunosuppressive features were consistent with the ssGSEA findings, which showed enrichment of pathways associated with immunosuppressive and tumor-promoting processes, including IL-6/STAT3 signaling, TGF-β signaling, hypoxia, EMT, and angiogenesis (Figure 7C). The gene discussed is STAT3; the disease is neoplasm.